COVID-19 VAX Booster Dosing in Patients With Hematologic Malignancies

NCT05028374 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

119

Enrollment

OTHER

Sponsor class

Conditions

Multiple Myeloma
AL Amyloidosis
Chronic Lymphocytic Leukemia

Interventions

DRUG: A single "booster" dose of the Moderna mRNA COVID-19 vaccine

Sponsor

Barbara Ann Karmanos Cancer Institute